BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3798216)

  • 1. [Functional status of lymphocytes in malignant tumors of the ovaries].
    Sokolova II; Repina FB; Antoshechkina ET; Shuvaeva NI
    Sov Med; 1986; (9):28-31. PubMed ID: 3798216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of cellular immunologic response in the stroma of early embryonic ovarian tumors of the gonadoblastoma type].
    Kozłowski H; Hrabowska M; Walkowicz E
    Patol Pol; 1979; 30(2):229-37. PubMed ID: 314620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of circulating T-lymphocytes in epithelial tumors of the ovary and during chemotherapy].
    Bolis PF; Franchi M; Guaschino S; Maccario R
    Ann Ostet Ginecol Med Perinat; 1982; 103(3):202-5. PubMed ID: 6982650
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological status of patients with solid neoplasms].
    Citterio F; Luciani G; Pozzetto U; Castagneto M
    Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on lymphocyte subpopulation, T cell subsette and lymphocyte responses to lectin of patients with malignant tumors].
    Oki H; Isshiki T; Sasano M; Takashima A; Chinen Y
    Rinsho Byori; 1984 Feb; 32(2):159-64. PubMed ID: 6610777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on the immune response in patients with chronic renal failure, with special reference to the peripheral blood lymphocyte subpopulation].
    Miyazawa S
    Fukuoka Igaku Zasshi; 1984 Aug; 75(8):469-83. PubMed ID: 6510870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional properties and membrane markers of lymphocytes in stored blood for transfusion].
    Molaro GL; De Paoli P; Santini GF
    Riv Emoter Immunoematol; 1984; 31(1):63-72. PubMed ID: 6531622
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cellular and humoral immunity in patients with benign tumors and tumor-like formations of ovaries].
    Selezneva ND; Kadagidze ZG; Andikian SI; Veskova TK; Zhogoleva IB
    Sov Med; 1982; (4):37-41. PubMed ID: 6980484
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
    Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
    Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
    De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
    Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer.
    Berek JS; Bast RC; Lichtenstein A; Hacker NF; Spina CA; Lagasse LD; Knapp RC; Zighelboim J
    Obstet Gynecol; 1984 Nov; 64(5):708-14. PubMed ID: 6493663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T and B lymphocytes, IgG, IgA and IgM in women with genital neoplasms].
    Paruch J; Lisiewicz J; Liber Z
    Wiad Lek; 1982 Oct; 35(18):1143-8. PubMed ID: 7179988
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of immunocellular resistance to IL-2-activated lymphocytes within ovarian carcinoma cells.
    Papadopoulos AJ; Han X; Matossian-Rogers A; Raju KS
    Gynecol Oncol; 1995 Jun; 57(3):388-94. PubMed ID: 7774843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated (HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors.
    Miyazaki K; Shimada K; Katabuchi H; Arakane F; Arao S; Okamura H
    Gynecol Oncol; 1995 Sep; 58(3):362-7. PubMed ID: 7672702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on immunosuppression in the patient with lung cancer: character and function of lymphocytes (author's transl)].
    Inoue S
    Hokkaido Igaku Zasshi; 1982 Jan; 57(1):87-100. PubMed ID: 7076110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.